Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Reperfusion Injury

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Reperfusion Injury in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marcoli, M1
Cervetto, C1
Castagnetta, M1
Sbaffi, P1
Maura, G1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Reperfusion Injury

ArticleYear
5-HT control of ischemia-evoked glutamate efflux from human cerebrocortical slices.
    Neurochemistry international, 2004, Volume: 45, Issue:5

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adult; Aged; Aspartic Acid; Brain Ischemia; Cerebral Cortex;

2004